Preclinical Safety Evaluation of Vernolac, a Commercially Available Polyherbal Nutraceutical Comprising Vernonia zeylanica, Nigella sativa, Hemidesmus indica, Smilax glabra, and Leucas zeylanica, in Wistar Rats
Shalini K. Wijerathne, Epitawala Arachchige Oshadi, Sandani De Vass Gunawardane, Ashein Kothalawala, Tharindu Lakmal Dissanayake, Gayani Ranaweera, Arumugam Murugananthan, Prasanna Galhena, Kanishka Sithira Senathilake, Sameera R. Samarakoon
This study evaluates the acute and 28-day repeat-dose toxicity of Vernolac in Wistar rats, finding no significant toxicity at up to four times the therapeutic dose.
bioRxiv · Dec 30, 2025 · PreprintPharmacology & Toxicology